Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination
PHASE3
The vaccination campaign in France began in early 2021 and was declared man...
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older
PHASE1
Study VBT00001 is planned to be a Phase 1/2, randomized, modified double-bl...
Status
Completed
Location
Simon Williamson Clinic - Birmingham- Site Number : 8400003